In this dynamic video from a live symposium, expert faculty discuss the clinical application of CGRP-targeting agents in migraine prophylaxis.
Slides on advances in prevention and acute treatment of migraine
My reflection on how far we’ve come in improving the treatment of acute and chronic migraine, from triptans and beta-blockers to small molecules and monoclonal antibodies that target CGRP.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.